F 0641
Ensure each resident receives an accurate assessment.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure the assessment accurately reflected the resident's
status for one of five residents (Resident #1) reviewed for accuracy of assessments.
Residents Affected - Some
The facility failed to ensure Resident #1's medications were correctly documented on his quarterly and
annual MDS assessments.
This failure could place residents at risk of inadequate care due to inaccurate assessments.
Findings included:
Record review of Resident #1's face sheet, printed on 01/08/25, reflected the resident was a [AGE] year-old
male who was admitted to the facility on [DATE]. Resident #1 had diagnoses which included metabolic
encephalopathy (brain dysfunction caused by an imbalance of chemicals in the blood), chronic embolism
and thrombosis of other specified veins (blood clots), end stage renal disease (a permanent condition
where the kidneys can no longer function properly), acute and chronic respiratory failure with hypoxia
(condition where the lungs are not effectively delivering oxygen to the body, causing a lack of oxygen in the
bloodstream), quadriplegia (the loss or severe impairment of motor function, sensation, and autonomic
functions in all four limbs (arms,legs and the torso), hypotension (low blood pressure), cerebral infarction (a
medical condition where brain tissue dies due to a disruption in blood flow to the brain), chronic pain,
anxiety disorder (mental health disorder characterized by feelings of worry, anxiety, or fear that are strong
enough to interfere with one's daily activities), major depressive disorder(mental health disorder
characterized by persistently depressed mood or loss of interest in activities, causing significant impairment
in daily life), type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy (a condition that occurs
when high blood sugar levels damage nerves in the body), peripheral vascular disease (a circulatory
condition that occurs when blood vessels outside of the brain and heart narrow, spasm, or become
blocked), schizophrenia (a chronic mental illness that affects a person's thoughts, feelings, and behaviors),
and essential (primary) hypertension(a condition where a person has high blood pressure without a clear
cause).
Record review of Resident #1's annual MDS assessment, dated 11/12/24, reflected Resident #1 had a
BIMS of 13, which indicated Resident #1 was cognitively intact. Question N0415. High-Risk Drug Classes:
Use and Indication, indicated Resident #1 had taken none of the above listed medications by classification
in the last seven days (prior to assessment).
Record review of Resident #1's quarterly MDS assessment, dated 12/12/24, reflected Resident #1 had a
BIMS score of 11, which indicated a moderate cognitive impairment. Question N0415. High-Risk Drug
Classes: and Indication, indicated Resident #1 had taken antipsychotic, antianxiety, and
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
676141
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676141
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/08/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Matlock Place Health & Rehabilitation Center
7100 Matlock Rd
Arlington, TX 76002
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
anticonvulsants in the last seven days (prior to assessment).
Level of Harm - Minimal harm
or potential for actual harm
Record review of the physician orders tab of Resident #1's electronic health record reflected the following
medication orders:
Residents Affected - Some
Lyrica Oral Capsule 50 MG (Pregabalin) Give 1 capsule by mouth at bedtime for Pain. -Start Date- 07/11/24
-D/C Date- 12/06/24
Melatonin Oral Tablet 5 MG (Melatonin) Give 1 tablet by mouth at bedtime for insomnia -Start Date07/11/24 -D/C Date- 12/06/24
Apixaban Oral Tablet 2.5 MG (Apixaban) Give 1 tablet by mouth two times a day for anticoagulant -Start
Date- 07/10/24 -D/C Date-12/06/24
Neurontin Oral Capsule 300 MG (Gabapentin) Give 1 capsule by mouth two times a day for
:anticonvulsants -Start Date- 07/10/24
-D/C Date- 12/06/24
Norco Oral Tablet 5-325 MG (Hydrocodone-Acetaminophen) Give 1 tablet by mouth two times a day for
pain -Start Date- 09/14/24 -D/C Date-12/06/24
Ziprasidone HCl Capsule Give 20 mg by mouth two times a day for Schizophrenia. Start Date- 07/11/24
-D/C Date- 12/06/24
Norco Oral Tablet 5-325 MG (Hydrocodone-Acetaminophen) Give 1 tablet by mouth every 6 hours as
needed for severe pain 7-10 hold for SBP <100 and or HR <60 -D/C Date- 12/06/24
Tramadol HCl Oral Tablet 50 MG (Tramadol HCl) Give 1 tablet by mouth every 6 hours as needed for
Moderate pain Can be given with Tylenol 325, 1 tab -D/C Date- 12/06/24
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676141
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676141
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/08/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Matlock Place Health & Rehabilitation Center
7100 Matlock Rd
Arlington, TX 76002
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Pregabalin Oral Capsule 50 MG (Pregabalin) Give 1capsule by mouth at bedtime for neuropathy. Start
Date- 12/08/24 -D/C Date-12/20/24
Tramadol HCl Oral Tablet 50 MG (Tramadol HCl). Give 1 tablet by mouth every 6 hours as needed for
moderate or severe pain, Start Date- 12/08/24 -D/C Date-12/20/24
Geodon Oral Capsule 20 MG (Ziprasidone HCl) Give 1 capsule by mouth two times a day for
Schizophrenia. Start Date- 12/08/24 -D/C Date-12/20/24
Eliquis Oral Tablet 2.5 MG (Apixaban) Give 1 tablet by mouth two times a day. Start Date- 12/08/24 -D/C
Date-12/20/24
Doxycycline Hyclate Oral Capsule (Doxycycline Hyclate) Give 100 mg by mouth two times a day for PNA
for 10 Days. Start Date- 12/11/24 -D/C Date-12/20/24
Acetaminophen-Codeine Oral Tablet 300-30 MG (Acetaminophen w/ Codeine) Give 1 tablet by mouth every
6 hours as needed for moderate pain. Start Date- 12/08/24 -D/C Date-12/20/24
Record review of Resident #1's November and December 2024 MARs reflected the resident medications
were administered according to physician orders and PRN medications (Norco and Tramadol) were
administered to Resident #1 on 11/05/24, 11/07/24, 11/12/24, 12/05/24, and 12/10/24.
In an interview on 01/09/25 at 4:50 p.m., the MDS Coordinator stated she had been the facility's MDS
Coordinator for roughly 3 years. She stated she was unaware Resident #1's medication were not recorded
accurately on his Annual and quarterly MDS. She stated she and another staff member were responsible
for the completion of all MDS assessment, but she completed Resident #1's. She stated after establishing
the appropriate look-back period, medical documentation (like hospital discharge orders, skilled nursing
notes current physician orders, and medication administration) to complete the MDS assessment. She
stated section N of the assessment was where medications were reported according their classification and
Section J asked for the use of the medication. She stated the MDS assessment was utilized to develop a
plan of care for a resident. She stated care planning was completed by the interdisciplinary team and any
missed medications and interventions were in place but any missed information could lead to a lack of
needed care, monitoring or services for the resident. She stated she would develop a process to check
assessments for accuracy.
In an interview on 01/08/25 at 5:37 p.m., the DON stated the MDS Coordinator notified her of the
inaccuracies of Resident #1's MDS assessments prior to her interview with the state surveyor. The DON
stated it was expected for all resident assessments to be accurate to show the entire picture of the
resident's condition. The DON stated not doing so could potentially lead to
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676141
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676141
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
01/08/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Matlock Place Health & Rehabilitation Center
7100 Matlock Rd
Arlington, TX 76002
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
misinformation/understanding of a resident condition, which could affect the care residents received. The
DON stated she and the MDS Coordinator were responsible for the accuracy of the MDS assessments, as
the MDS Coordinator completed the assessment, and she finalized the assessment. The DON stated she
would audit all MDS assessments, in-service staff and monitor assessment to ensure their accuracy.
In an interview on 01/08/25 at 5:53 p.m., the Administrator stated the DON notified him of the inaccuracies
of Resident #1's MDS assessments. The Administrator stated he expected for assessments to be accurate,
as not doing so could lead to the resident receiving a lower level of care. The Administrator stated the MDS
Coordinator, DON and ADONs were responsible for all facility assessments, which included the MDS. The
Administrator stated he planned to Inservice staff over accurate assessments and would get with the MDS
Coordinator and the DON to develop a process to monitor and review assessments for their accuracy
before they were finalized.
A related policy was requested from the DON on 01/08/25 at 5:37 p.m. but was not provided prior to exit.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
676141
If continuation sheet
Page 4 of 4